penicillin g has been researched along with Cystic Fibrosis in 7 studies
Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of ticarcillin-induced hemorrhagic cystitis is presented, and the literature on drug-induced hemorrhagic cystitis is reviewed." | 3.67 | Drug-induced hemorrhagic cystitis. ( Relling, MV; Schunk, JE, 1986) |
| "The emergence of beta-lactam-resistant strains of Pseudomonas aeruginosa in a cystic fibrosis patient treated with high-dose tobramycin and piperacillin was studied." | 3.66 | beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. ( Bryan, LE; Godfrey, AJ; Rabin, HR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moss, RB | 1 |
| Babin, S | 1 |
| Hsu, YP | 1 |
| Blessing-Moore, J | 1 |
| Lewiston, NJ | 1 |
| Godfrey, AJ | 1 |
| Bryan, LE | 1 |
| Rabin, HR | 1 |
| Cade, A | 1 |
| Denton, M | 1 |
| Brownlee, KG | 1 |
| Todd, N | 1 |
| Conway, SP | 1 |
| Bins, JW | 1 |
| Mattie, H | 1 |
| Relling, MV | 1 |
| Schunk, JE | 1 |
| Eftimiadi, C | 1 |
| De Leo, C | 1 |
| Schito, GC | 1 |
| Goddard, RF | 1 |
| Mercer, TT | 1 |
| O'Neill, PX | 1 |
| Flores, RL | 1 |
| Sanchez, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single Arm 48-Week Follow-on Safety Study to the Core Study (A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb®/Actitob®/Bramitob® (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vi[NCT01111383] | Phase 3 | 209 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for penicillin g and Cystic Fibrosis
| Article | Year |
|---|---|
Allergy to semisynthetic penicillins in cystic fibrosis.
Topics: Adolescent; Adult; Benzeneacetamides; Carbenicillin; Child; Cystic Fibrosis; Drug Hypersensitivity; | 1984 |
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cystic Fibros | 1981 |
Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis.
Topics: Acute Disease; Child; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Floxacillin; Hum | 1999 |
The tubular excretion of benzylpenicillin in patients with cystic fibrosis.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Kidney Tubules; M | 1989 |
Drug-induced hemorrhagic cystitis.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Cystic Fibrosis; Cystitis; Hematuria; Humans; Male; | 1986 |
Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
Topics: Ampicillin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Humans; Methods; Microbial Sensitivity Tests | 1985 |
Output characteristics and clinical efficacy of ultrasonic nebulizers.
Topics: Acetylcysteine; Aerosols; Asthma; Bronchial Diseases; Child; Cortisone; Cystic Fibrosis; Humans; Muc | 1968 |